Communiqués Denka Company Limited

Actions

4061

JP3549600009

Produits chimiques de base

Temps Différé Japan Exchange 02:55:20 02/10/2026			Varia. 5j.	Varia. 1 janv.
3 208,00 ^JPY	-0,87%		-4,27%	+16,97%

08/09	Les actions japonaises font du surplace face à la flambée du yen et aux anticipations de la BoJ	RE
21/08	Denka Company Limited : SBI Securities favorable au dossier	ZM

Communiqués

01/10	Denka : to Showcase Cell Culture Ware at BioJapan 2026	PU
19/08	Denka : FY2026 First Quarter Financial Results Presentation Summary of Q&A Session	PU
26/05	Denka : FY2025 4Q Financial Results Presentation Summary of Q&A Session	PU
15/05	Denka : FY2025 Financial Results Presentation Materials with Script	PU
13/05	Denka : Notice Concerning Recording of Extraordinary Income and Losses (Consolidated and Non-consolidated)	PU
13/05	Denka : Results Presentation of FY2025	PU
13/05	Denka : FY2025 Summary of Consolidated Financial Statements	PU
26/03	Notice Regarding Results of Tender Offer for Share Certificates, Etc. of KAINOS Laboratories, Inc. (Securities Code: 4556)	PU
26/03	Denka : Announcement of Extraordinary Gains (Gain on Sale of Investment Securities)	PU
12/03	Denka : Summary of Q&A Session for Management Presentation on Feb 27 2025	PU
09/03	Denka : Notice Concerning Change in Equity-Method Affiliate (Becoming a Consolidated Subsidiary)	PU
05/03	Denka : Presentation Materials for Management Presentation on Feb 27 2026 with Script	PU
05/03	(Amendment) Notice Regarding Amendment to “Notice Regarding Commencement of Tender Offer for Share Certificates, Etc. of KAINOS Laboratories, Inc. (Securities Code: 4556)” and Public Notice of Commencementof Tender Offer Dueto Filingof Amendment Statement	PU
27/02	Denka : Notice of Formulation of Management Plan “Mission 2030” Phase 2 (FY2026–FY2028)	PU
27/02	Denka : Presentation Material for Management Presentation on Feb 27th 2026	PU
17/02	Denka : FY2025 Third Quarter Financial Results Presentation Summary of Q&A Session	PU
13/02	Denka : FY2025 Third Quarter Financial Results Presentation Materials with Script	PU
09/02	Notice Regarding Commencement of Tender Offer for Share Certificates, Etc. of KAINOS Laboratories, Inc. (Securities Code: 4556)	PU
06/02	Denka : Notice Regarding Personnel Changes in Executive Officers	PU
06/02	Denka : FY2025 Third Quarter Financial Results Presentation Materials	PU
06/02	Denka : FY2025 Third Quarter Summary of Consolidated Financial Results	PU
22/01	Denka : Awarded “A-” for Climate Change and “A” rating for Water Security in CDP 2025	PU
25/11	Denka : FY2025 Second Quarter Financial Results Presentation Summary of Q&A Session	PU
13/11	FY 2025 Second Quarter Financial Results Presentation Materials with Script (Financial Results and Topic: Direction of Management Plan Mission 2030 Revision)	PU
10/11	Denka : Notice Regarding Recognition of Extraordinary Losses	PU